Pharmacy Leaflets Become Focus For Patient Safety; IoM, FDA Finalize Standards
Executive Summary
Producers of consumer medication information leaflets are hoping that FDA provides them with more time to come into compliance with standards for usefulness, even as an Institute of Medicine report is emphasizing the need for quality in the materials
You may also be interested in...
FDA Poised To Overhaul Distribution Of Consumer Medical Information
FDA appears poised to begin an overhaul of the dissemination of consumer drug information
FDA Poised To Overhaul Distribution Of Consumer Medical Information
FDA appears poised to begin an overhaul of the dissemination of consumer drug information
FDA Risk Communication Advisory Cmte. Will Assess Pharmacy Leaflets’ Utility
FDA's Risk Communication Advisory Committee will meet Feb. 26-27 to discuss how to improve the usability of consumer medical information leaflets distributed by pharmacies with prescription drugs